Rituximab for the treatment of systemic sclerosis: urgent need for an international randomised controlled trial

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{a2b456f9fae9423499fd0f15078191a9,

title = "Rituximab for the treatment of systemic sclerosis: urgent need for an international randomised controlled trial",

author = "Michael Hughes",

year = "2021",

month = may,

doi = "10.1016/s2665-9913(21)00149-1",

language = "English",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Rituximab for the treatment of systemic sclerosis: urgent need for an international randomised controlled trial

AU - Hughes, Michael

PY - 2021/5

Y1 - 2021/5

UR - http://dx.doi.org/10.1016/s2665-9913(21)00149-1

U2 - 10.1016/s2665-9913(21)00149-1

DO - 10.1016/s2665-9913(21)00149-1

M3 - Article

SN - 2665-9913

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

ER -